levonorgestrel has been researched along with Deep Vein Thrombosis in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (10.34) | 18.2507 |
| 2000's | 18 (62.07) | 29.6817 |
| 2010's | 8 (27.59) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brand, JL; Jordan, K; Marshall, M; Welborn, TL | 1 |
| de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A | 1 |
| Galloula, A; Gautier, V; Messas, E; Minozzi, C; Mirault, T; Rossi, A | 1 |
| Helmerhorst, FM; Rosendaal, FR; Rosing, J; Tchaikovski, SN; van Vliet, HA | 1 |
| Rosing, J; Tchaikovski, SN | 1 |
| Chen, CS; Lee, AW; Matti, AI | 1 |
| Helmerhorst, FM; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Lidegaard, O; Løkkegaard, E; Nielsen, LH; Skovlund, CW | 1 |
| Cannegieter, SC; Helmerhorst, FM; Lijfering, WM; Roach, RE; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Bouma, BN; Deguchi, H; Griffin, JH; Lee, YM; Middeldorp, S | 1 |
| Szarewski, A | 1 |
| Alvarez-Sabin, J; de Francisco, J; Garcia-Martinez, R; Horga, A; Quilez, A; Santamarina, E | 1 |
| Weiss, G | 1 |
| Farmer, RD; Lawrenson, R; Leydon, GM; Todd, J; Williams, TJ | 1 |
| Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
| Kluft, C | 1 |
| Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; van den Ende, AE; van Enk, A | 1 |
| Colau, JC | 1 |
| Ellison, J; Greer, IA; Thomson, AJ; Walker, ID | 1 |
| Meurer, LN; Slawson, JG | 1 |
| Bounds, W; Furs , SA; Guillebaud, J; Johnson, J; Machin, SJ; Mackie, IJ; Piegsa, K | 1 |
| Berlin, JA; Hennessy, S; Kinman, JL; Marcus, SM; Margolis, DJ; Strom, BL | 1 |
| Jick, H; Vasilakis-Scaramozza, C | 1 |
| Milsom, I; Odlind, V; Ostlund, I; Persson, E; von Schoultz, B | 1 |
| Milsom, I; Odlind, V; Persson, I; Victor, A | 1 |
| Black, C; Jick, H; Kaye, JA | 1 |
6 review(s) available for levonorgestrel and Deep Vein Thrombosis
| Article | Year |
|---|---|
Combined oral contraceptives: venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis | 2014 |
[Portal vein thrombosis associated with an acute cytomegalovirus infection].
Topics: Acute Disease; Anticoagulants; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cytomegalovirus Infections; Ethinyl Estradiol; Female; Heparin, Low-Molecular-Weight; Hepatitis, Viral, Human; Humans; Levonorgestrel; Portal Vein; Venous Thrombosis; Warfarin; Young Adult | 2014 |
Mechanisms of estrogen-induced venous thromboembolism.
Topics: Blood Coagulation Factors; Contraception; Contraceptive Agents; Contraceptives, Oral; Estrogens; Female; Hemostasis; Humans; Levonorgestrel; Risk; Risk Factors; Venous Thromboembolism; Venous Thrombosis | 2010 |
Hormonal contraception: recent advances.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethisterone; Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Norgestrel; Oximes; Venous Thrombosis; Women's Health | 2006 |
[Contraception].
Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraindications; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Progestins; Risk Factors; Stroke; Venous Thrombosis; Vinyl Compounds | 2000 |
Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis.
Topics: Contraceptives, Oral; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Risk Factors; Venous Thrombosis | 2001 |
4 trial(s) available for levonorgestrel and Deep Vein Thrombosis
| Article | Year |
|---|---|
The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC).
Topics: Activated Protein C Resistance; Adult; Biomarkers; Contraceptives, Oral, Combined; Female; Genetic Predisposition to Disease; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pedigree; Risk Assessment; Risk Factors; Thrombin; Time Factors; Venous Thrombosis; Young Adult | 2009 |
Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.
Topics: Activated Protein C Resistance; Chromatography, High Pressure Liquid; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Glucosylceramides; Humans; Levonorgestrel; Pilot Projects; Protein C; Protein S; Prothrombin Time; Risk; Sensitivity and Specificity; Venous Thrombosis | 2005 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Topics: Adolescent; Adult; Antithrombin III; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Humans; Levonorgestrel; Peptide Fragments; Peptide Hydrolases; Prothrombin; Risk Factors; Thrombin; Thrombophilia; Venous Thrombosis | 2000 |
19 other study(ies) available for levonorgestrel and Deep Vein Thrombosis
| Article | Year |
|---|---|
In women over 35 years of age who smoke, does mirena (levonorgestrel-releasing intrauterine system) reduce the risk of DVTs compared to oral contraceptives?
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral; Evidence-Based Medicine; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Risk Assessment; Venous Thrombosis | 2013 |
Concurrent branch retinal vein occlusion and cerebral venous thrombosis from oral contraceptive pill use.
Topics: Adult; Cerebral Veins; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Magnetic Resonance Angiography; Ophthalmoscopy; Phlebography; Retinal Vein Occlusion; Venous Thrombosis; Visual Acuity | 2010 |
The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Risk Factors; Venous Thrombosis; Young Adult | 2010 |
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Topics: Adolescent; Adult; Anticoagulants; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Denmark; Drug Implants; Epidemiologic Methods; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Transdermal Patch; Venous Thrombosis; Young Adult | 2012 |
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Topics: Administration, Cutaneous; Age Factors; Aged; Case-Control Studies; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Norethindrone; Norethindrone Acetate; Odds Ratio; Postmenopause; Progestins; Risk Assessment; Risk Factors; Sex Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Venous thrombosis with cyproterone.
Topics: Androgen Antagonists; Case-Control Studies; Contraceptive Agents, Female; Cyproterone; Female; Humans; Levonorgestrel; Venous Thrombosis | 2002 |
Venous thrombosis with cyproterone (continued).
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Canada; Contraceptives, Oral, Hormonal; Cyproterone; Female; France; Humans; Levonorgestrel; Risk Factors; Venous Thrombosis | 2004 |
Cerebral venous thrombosis associated with repeated use of emergency contraception.
Topics: Anticoagulants; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Factor VIII; Female; Humans; Intracranial Thrombosis; Levonorgestrel; Middle Aged; Venous Thrombosis | 2007 |
Risk of venous thromboembolism with third-generation oral contraceptives: A review.
Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Risk Factors; Thromboembolism; Venous Thrombosis | 1999 |
Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Odds Ratio; Risk Factors; Smoking; United Kingdom; Venous Thrombosis | 1999 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
Renewed interest in haemostasis changes induced by oral contraceptives (OCs)
Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Genetic Predisposition to Disease; Hemostasis; Humans; Levonorgestrel; Partial Thromboplastin Time; Randomized Controlled Trials as Topic; Thrombophilia; Venous Thrombosis | 2000 |
Drug Points: Apparent interaction between warfarin and levonorgestrel used for emergency contraception.
Topics: Adult; Anticoagulants; Drug Interactions; Emergencies; Female; Fibrin; Humans; Levonorgestrel; Pulmonary Embolism; Venous Thrombosis; Warfarin | 2000 |
What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism; Venous Thrombosis | 2001 |
Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over.
Topics: Adult; Analysis of Variance; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein S; Risk; Venous Thrombosis | 2001 |
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives.
Topics: Adult; Androgen Antagonists; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Cyproterone; Female; Humans; Levonorgestrel; Risk Factors; Smoking; Venous Thrombosis | 2001 |
[Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraindications; Desogestrel; Drug Information Services; Drug Prescriptions; Female; Humans; Levonorgestrel; Practice Guidelines as Topic; Progestins; Risk Factors; Thromboembolism; Venous Thrombosis | 2002 |
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis | 2002 |
Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Risk Factors; Thromboembolism; Venous Thrombosis | 2002 |